Korro Bio (KRRO) Assets Average (2019 - 2026)

Korro Bio's Assets Average history runs 8 years deep, the most recent figure standing at $148.6 million for Q1 2026.

• Quarterly Assets Average fell 30.65% year-over-year to $148.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.6 million (down 30.65% YoY) and the FY2025 annual result came in at $169.9 million, down 24.15% from the prior year.
• Assets Average was $148.6 million for Q1 2026 at Korro Bio, up from $137.5 million in the prior quarter.
• Across five years, Assets Average topped out at $246.6 million in Q3 2024 and bottomed at $62.9 million in Q3 2023.
• A 5-year average of $160.8 million and a median of $157.3 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average plunged 55.99% — and 2024, when it soared 292.21%.
• Korro Bio's Assets Average stood at $104.9 million in 2022, then rose by 27.77% to $134.0 million in 2023, then soared by 75.28% to $234.9 million in 2024, then slumped by 41.45% to $137.5 million in 2025, then gained by 8.02% to $148.6 million in 2026.
• Business Quant data shows KRRO's Assets Average at $148.6 million in Q1 2026, $137.5 million in Q4 2025, and $171.0 million in Q3 2025.